ライフサイエンスコーパス: congenital heart block

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 provide new insight into the pathogenesis of congenital heart block.

2 lained despite their strong association with congenital heart block.

3 bs, particularly 52Ro, in the development of congenital heart block.

4 s it pertains to ventricular arrhythmias and congenital heart block.

5 tions of neonatal lupus (cardiac NL) include congenital heart block and cardiomyopathy.

6 (19%) in mothers with a previous child with congenital heart block and in 3 of 74 pregnancies (4%) i

7 Despite the near universal association of congenital heart block and maternal Abs to SSA/Ro and SS

8 ibodies give birth to children with complete congenital heart block and photosensitive skin lesions.

9 Rs), as did cardiac tissue from a fetus with congenital heart block (CHB) and an age-matched control.

10 ance in the description and understanding of congenital heart block (CHB) came in the 1970s with the

11 he recurrence rate of anti-SSA/Ro-associated congenital heart block (CHB) is 17%.

12 Congenital heart block (CHB) is a conduction abnormality

13 Congenital heart block (CHB) is a disease that affects t

14 Congenital heart block (CHB) is an autoimmune disease th

15 It is a widely held view that congenital heart block (CHB) is caused by the transplace

16 signature lesion of autoantibody-associated congenital heart block (CHB) is fibrosis of the conducti

17 Congenital heart block (CHB) is presumed to be caused by

18 Autoimmune associated congenital heart block (CHB) may result from pathogenic

19 Identification of isolated congenital heart block (CHB) predicts, with near certain

20 nd recurrence rates of autoimmune-associated congenital heart block (CHB) using information from the

21 IC) may be relevant in autoimmune-associated congenital heart block (CHB) where the obligate factor i

22 We report 16 infants with complete congenital heart block (CHB) who developed late-onset di

23 Congenital heart block (CHB), associated with antibodies

24 In congenital heart block (CHB), binding of maternal anti-S

25 -SSB/La are necessary for the development of congenital heart block (CHB), the low frequency suggests

26 tion of the atrioventricular node leading to congenital heart block (CHB).

27 ated from 83 children (22 with rash, 35 with congenital heart block [CHB], 26 unaffected siblings) an

28 efficacious after in utero identification of congenital heart block, especially in fetuses with assoc

29 maternal autoantibodies with the genesis of congenital heart block, female BALB/c mice were immunize

30 syndrome, systemic lupus erythematosus, and congenital heart block from anti-Ro52 Ab-positive mother

31 There was a trend toward more congenital heart block in fetuses of women with previous

32 suggest that hydroxychloroquine may prevent congenital heart block in pregnancies exposed to SSA/Ro

33 Congenital heart block is considered a model of passivel

34 Anti-SSA/Ro-associated third-degree congenital heart block is irreversible, prompting a sear

35 4%) in mothers without a previous child with congenital heart block or rash (P=0.067).

36 The risk of having a subsequent child with congenital heart block ranges between 12-16%.

37 pathogenesis of neonatal lupus syndrome and congenital heart block reveals important information abo

38 he candidate antibodies to have a child with congenital heart block was at or below one in 50.

39 Congenital heart block was diagnosed in utero in 12 pati

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。